Bio and generic demand driving increased internationalisation and renewed optimism amongst industry The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead ofCPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open its
MoreShanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai
MoreBangkok: SE Asian demand for manufacturing is being driven by recent regulatory changes and increased generics from Indonesia, Malaysia and the
MoreShanghai: CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo – takes place at
MoreCPhI South East Asia’s (March 12-14, 2019) first visit to the fast-growing pharma economy of Thailand could not come at
MoreBio and generic demand driving increased internationalisation and renewed optimism amongst industry The Japanese pharma market is expected to grow
MoreBio capacity in Europe is predicted to overtake the USA by 2020 according to the bio findings of CPhI Annual
MoreAt the upcoming CPhI Worldwide in Madrid, Romaco will share booths with its industry partners Huhtamaki, Biogrund, Hennig Arzneimittel and
MoreThe Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12
MoreCPhI Worldwide – organised by UBM (part of Informa PLC) – announces the opening of the 2018 CPhI Pharma Awards
MoreP-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 June. The event
More